Growth Metrics

Iterum Therapeutics (ITRM) Tax Provisions (2017 - 2022)

Historic Tax Provisions for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to $101000.0.

  • Iterum Therapeutics' Tax Provisions fell 4093.57% to $101000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $301000.0, marking a year-over-year decrease of 5730.5%. This contributed to the annual value of $240000.0 for FY2024, which is 6084.83% down from last year.
  • As of Q4 2022, Iterum Therapeutics' Tax Provisions stood at $101000.0, which was down 4093.57% from -$570000.0 recorded in Q3 2022.
  • Over the past 5 years, Iterum Therapeutics' Tax Provisions peaked at $427000.0 during Q1 2022, and registered a low of -$570000.0 during Q3 2022.
  • Moreover, its 5-year median value for Tax Provisions was $121500.0 (2020), whereas its average is $133250.0.
  • In the last 5 years, Iterum Therapeutics' Tax Provisions skyrocketed by 61250.0% in 2021 and then tumbled by 26193.18% in 2022.
  • Quarter analysis of 5 years shows Iterum Therapeutics' Tax Provisions stood at $206000.0 in 2018, then tumbled by 76.21% to $49000.0 in 2019, then crashed by 51.02% to $24000.0 in 2020, then surged by 612.5% to $171000.0 in 2021, then crashed by 40.94% to $101000.0 in 2022.
  • Its Tax Provisions stands at $101000.0 for Q4 2022, versus -$570000.0 for Q3 2022 and $343000.0 for Q2 2022.